(Q34095683)

31 July 2017

1 reference

title

Helicobacter pylori: past, present and future. (English)

1 reference

31 July 2017

0 references

Tytgat G

1

1 reference

31 July 2017

publication date

1 October 2000

1 reference

Journal of Gastroenterology and Hepatology

31 July 2017

published in

1 reference

31 July 2017

volume

15 Suppl

1 reference

31 July 2017

page(s)

G30-3

1 reference

Helicobacter pylori-dependent ceramide production may mediate increased interleukin 8 expression in human gastric cancer cell lines

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

Antibacterial peptide from H. pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

Geographic distribution of vacA allelic types of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02262.X

10.1046/J.1440-1746.2000.02262.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference